analysis

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc.,…

2 weeks ago

Xinhua Silk Road: Annual analysis report on taro price index released at the 2024 Boao Forum for Entrepreneurs

BEIJING, Dec. 5, 2024 /PRNewswire/ -- The annual analysis report on the taro price index was released during the 2024…

2 weeks ago

Xinhua Silk Road: Annual analysis report on taro price index released at the 2024 Boao Forum for Entrepreneurs

BEIJING, Dec. 5, 2024 /PRNewswire/ -- The annual analysis report on the taro price index was released during the 2024…

3 weeks ago

Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban

November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…

1 month ago

Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban

November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…

1 month ago

WorldInvest.org Enhances Trading Experience with Expert Analysis Team to Guide Market Decisions

New York, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- WorldInvest.org Strengthens Market Insights for Traders with Dedicated Analysis Team. WorldInvest.org,…

1 month ago